ClinicalTrials.Veeva

Menu

IV Paracetamol vs IV Morphine vs Placebo in Sciatalgia

A

Akdeniz University

Status and phase

Unknown
Phase 4

Conditions

Sciatica

Treatments

Drug: Paracetamol
Drug: Placebo
Drug: morphine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Siatalgia is one of the main symptoms related to emergency department presentations. Patients with sciatalgia are seeking for immediate pain relief and little known regarding the pain management of these patients in emergency department. This study aim to trial the effect of intravenous paracetamol and morphine in patients presented with sciatalgia to emergency department.

Full description

Siatalgia is one of the main symptoms related to emergency department presentations. Patients with sciatalgia are seeking for immediate pain relief and little known regarding the pain management of these patients in emergency department. Neuronal compression is the main cause of pain in sciatalgia rather than inflammation which also differ sciatalgia from the other type of pains in emergency department. Sciatalgia is a kind of neuralgia and there is not so much option in the pain management of these patients. Intravenous paracetamol and morphine is commonly used analgesics in various kind of pain in emergency department. So, this study aim to trial the effect of intravenous paracetamol and morphine in patients presented with sciatalgia to emergency department.

Enrollment

300 estimated patients

Sex

All

Ages

21 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with pain radiating to the sciatic nerve path
  • Pain within the last one week
  • Patients with positive straight leg raise
  • Patients over 21 and lower than 65 years old

Exclusion criteria

  • Pain score lower than 40 mm in visual analogue scale score
  • Neurological deficit
  • Allergy to the study drugs
  • Unstable vital signs
  • History of malignancy or rheumatological diseases or arthritis
  • History of chronic pain syndrome
  • Receiving pain killer, steroid, anti-depressant, anti-convulsant and musculorelaxant within the last six hours.
  • Drug or alcohol addiction
  • Pregnancy or breast feeding
  • Fewer more than 37.9 Celsius degrees.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

300 participants in 3 patient groups, including a placebo group

Paracetamol
Active Comparator group
Description:
1 g intravenous paracetamol (Perfalga, Bristol Myers) in 100 ml saline with a rapid infusion.
Treatment:
Drug: Paracetamol
morphine
Active Comparator group
Description:
0.1 mg/kg morphine in 100 ml saline with a rapid infusion.
Treatment:
Drug: morphine
placebo
Placebo Comparator group
Description:
100 ml saline
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Mustafa Serinken, MD; Cenker Eken, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems